Main Conference – Day 2 - CET (Central European Time, GMT+01:00)
Our distinguished panelists will share their journeys of building successful biotech ventures, overcoming industry challenges, and translating cutting-edge RNA science into life-changing treatments. Discover the latest developments in RNA therapeutics, learn about emerging opportunities in this rapidly evolving field, and gain insights into what it takes to lead innovation in one of biotech's most promising sectors.
- Paola Pozzi - Partner, Sofinnova Telethon Fund, Sofinnova Partners
- Malgorzata Gonciarz - Global Head xRNA Therapeutics, Novartis
- Tamar Grossman - CEO, La Jolla Labs
- Sonja Merkas, PhD - Founder, Creator and Doer, Livinovea
- Synthesis and Modifications of RNA Modalities
Overlooked Opportunities in RNA Therapeutics
Translational Challenges in Scaling RNA Medicines
PK/PD Measurement Requirements
Control Elements and UTR Considerations
Limitations of Animal Models and Human Alternatives
Safety versus Efficacy Balance in RNA Therapeutics
AI adoption for Discovery and Target Selection
Enzymatic Approaches in RNA Production
Extrahepatic delivery of RNA cargos
